Contract Pharmaceutical Manufacturing, Research, and Packaging

Home >
Life Sciences >
Pharmaceutical >
Contract Pharmaceutical Manufacturing, Research, and Packaging

Contract Pharmaceutical Manufacturing, Research, and Packaging

Report price : $ 4 850
Publication date : August 2007

Contract Pharmaceutical Manufacturing, Research, and Packaging

This report contains: The current market status for contract manufacturing, research, and packaging and forecasts for growth through 2011; Discussion of the advantages and disadvantages of outsourcing; Technological issues including the latest trends and developments; Descriptions of each market's need for outsourcing, risks and regulatory environment; A break down of revenues by the bulk as well as by the dosage forms of solid, liquid and semisolid.

INTRODUCTION STUDY OBJECTIVES REASONS FOR DOING THIS STUDY CONTRIBUTIONS OF THE STUDY AND FOR WHOM SCOPE OF THE STUDY METHODOLOGY INFORMATION SOURCES ABOUT THE AUTHOR RELATED BCC RESEARCH REPORTS BCC ONLINE SERVICES DISCLAIMER

EXECUTIVE SUMMARY

SUMMARY TABLE GLOBAL PHARMACEUTICAL CONTRACT

MANUFACTURING AND CONTRACT RESEARCH

ORGANIZATIONS REVENUE FORECAST, THROUGH 2011 ($

BILLIONS)

SUMMARY FIGURE WORLDWIDE PHARMACEUTICAL CONTRACT

MANUFACTURING AND CONTRACT RESEARCH

ORGANIZATIONS REVENUE, 2004-2011 (BILLIONS)

OVERVIEW DEFINITIONS CONTRACT MANUFACTURING CONTRACT RESEARCH CONTRACT PACKAGING PACKAGING SERVICE SELECTION CRITERIA ADVANTAGES OF CONTRACT PACKAGING NEED FOR OUTSOURCING NEED FOR CONTRACT MANUFACTURING Flexibility Capacity and Capital Risks NEED FOR CONTRACT RESEARCH NEED FOR CONTRACT PACKAGING CAPABILITIES AND QUALITIES OF CONTRACT COMPANIES PROS AND CONS OF OUTSOURCING ADVANTAGES OF OUTSOURCING DISADVANTAGES OF OUTSOURCING CONTRACT REQUIREMENTS BASIC RISKS IN OUTSOURCING PARTNERSHIPS KEYS TO REDUCING RISKS KEYS TO CONTRACT ORGANIZATIONS MEETING CHALLENGES IN QUALITY AND REGULATORY REQUIREMENTS

TECHNOLOGY INTRODUCTION SELECTION OF AN OUTSOURCING PROVIDER CONTRACT MANUFACTURING ORGANIZATION REQUIREMENTS Term Sheet Manufacturing Agreement between the Parties Quality Agreement Technology Transfer Information Exchange Process Design and Process Logistics Process Description Production Requirements Plan Reviewing Production Details Perform Transfer Runs Implementation of the Production Requirements Plan Training Keys to a Good Relationship Client Involvement in Technology Transfer Team Meetings Management’s Involvement Contract Manufacturing Agreement Role of the Project Manager Role of the Project Manager (Continued)

REGULATORY ASPECTS REGULATORY COMPLIANCE REQUIREMENTS AGREEMENT BETWEEN CONTRACTOR AND CLIENT TO MEET REGULATIONS REGULATORY ISSUES IN CONTRACT MANUFACTURING USE OF CONSULTING FIRMS REGULATION OF API/BULK DRUG MANUFACTURING

INDUSTRY STRUCTURE MARKET SHARES OF INDUSTRY LEADERS CONTRACT MANUFACTURERS OF BULK DRUGS AND APIS

TABLE 1 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING BULK DRUGS/API, 2006 (%)

TABLE 1 (CONTINUED)

FIGURE 1 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING BULK DRUGS/API, 2006 (%)

CONTRACT MANUFACTURERS OF SOLID DOSAGE FORMS

TABLE 2 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SOLID DOSAGE FORMS, 2006 (%)

FIGURE 2 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SOLID DOSAGE FORMS, 2006 (%)

CONTRACT MANUFACTURERS OF LIQUID DOSAGE FORMS

TABLE 3 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING LIQUID DOSAGE FORMS, 2006 (%)

FIGURE 3 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING LIQUID DOSAGE FORMS, 2006 (%)

CONTRACT MANUFACTURERS OF SEMISOLID DOSAGE FORMS

TABLE 4 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, 2006 (%)

FIGURE 4 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, 2006 (%)

CONTRACT RESEARCH COMPANIES

TABLE 5 WORLDWIDE MARKET SHARES OF CONTRACT RESEARCH COMPANIES, 2006 (%)

FIGURE 5 WORLDWIDE MARKET SHARES OF CONTRACT RESEARCH COMPANIES, 2006 (%)

CONTRACT PACKAGING COMPANIES

TABLE 6 WORLDWIDE MARKET SHARES OF CONTRACT PACKAGING COMPANIES, 2006 (%)

FIGURE 6 WORLDWIDE MARKET SHARES OF CONTRACT PACKAGING COMPANIES, 2006 (%)

TYPES OF CONTRACT MANUFACTURING AND RESEARCH FIRMS

TABLE 7 SERVICES PROVIDED BY CONTRACT MANUFACTURING AND RESEARCH FIRMS

TABLE 7 (CONTINUED)

TABLE 8 SERVICES PROVIDED BY CONTRACT PACKAGING FIRMS BY PACKAGING TYPE

SUPPLY AND DEMAND

STRATEGIC TOOLS

TIME TO MARKET

CHALLENGES IN OUTSOURCING

IDENTIFICATION OF OUTSOURCING PARTNERS

FINANCIAL CONSIDERATIONS

PREFERRED PROVIDERS

INNOVATIVE PARTNERS

SUITABLE ALTERNATIVES

NEW DEVELOPMENTS ABBOTT LABORATORIES ALBANY MOLECULAR RESEARCH (AMRI) ASTELLAS PHARMA CAMBREX CARDINAL HEALTH CHEMBRIDGE GLAXOSMITHKLINE (GSK) MALLINCKRODT, INC. PATHEON SCHWARZ PHARMA

MARKETS BACKGROUND CONTRACT MANUFACTURING CONTRACT MANUFACTURE OF BULK DRUGS/APIS Contract Manufacture of … (Continued) Role of APIs in the Success of Generic Firms Role of Contract Manufacturer in API Product Development Market Leaders Market Revenue

TABLE 9 GLOBAL BULK DRUG/API CONTRACT MANUFACTURING REVENUE FORECAST BY REGION THROUGH 2011 ($ BILLIONS)

FIGURE 7 GLOBAL BULK DRUG/API CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, 2004-2011 ($ BILLIONS)

Market Shares

TABLE 10 GLOBAL BULK DRUG/API CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)

FIGURE 8 GLOBAL BULK DRUG/API CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)

CONTRACT MANUFACTURE OF ORAL DOSAGE

FORMULATIONS

Solid Dosage Formulations

Market Leaders

Market Revenue

TABLE 11 GLOBAL SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, THROUGH 2011 ($ BILLIONS)

FIGURE 9 GLOBAL SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, 2004-2011 (BILLIONS)

Market Shares

TABLE 12 GLOBAL SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)

FIGURE 10 GLOBAL SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)

Market by Formulation

Market Revenue

TABLE 13 GLOBAL SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE FORECAST BY FORMULATION, THROUGH 2011 ($ BILLIONS)

FIGURE 11 GLOBAL SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE FORECAST BY FORMULATION, 2004-2011 ($ BILLIONS)

TABLE 14 GLOBAL SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2006 (%)

FIGURE 12 GLOBAL SOLID DOSAGE FORM CONTRACT MANUFACTURING, MARKET SHARES BY FORMULATION, 2006 (%)

CONTRACT MANUFACTURE OF LIQUID DOSAGE

FORMULATIONS

Non-sterile Formulations

Market Revenue

TABLE 15 GLOBAL LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2011 ($ MILLIONS)

FIGURE 13 GLOBAL LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING REVENUE BY REGION, 2004-2011 ($ MILLIONS)

Market Shares

TABLE 16 GLOBAL LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)

FIGURE 14 GLOBAL LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)

Sterile Formulations

Market Leaders

Market Revenue

TABLE 17 GLOBAL LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE FORECAST, BY REGION, THROUGH 2011 ($ MILLIONS)

FIGURE 15 GLOBAL LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE FORECAST, BY REGION, THROUGH 2011 ($ MILLIONS)

Market Shares

TABLE 18 GLOBAL LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)

FIGURE 16 GLOBAL LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)

Market by Formulation

Non-sterile Formulations

TABLE 19 GLOBAL LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING REVENUE FORECAST, BY FORMULATION, THROUGH 2011 ($ MILLIONS)

FIGURE 17 GLOBAL LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING REVENUE BY FORMULATION, 2004-2011 ($ MILLIONS)

TABLE 20 GLOBAL LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2006 (%)

FIGURE 18 GLOBAL LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2006 (%)

Sterile Formulations

TABLE 21 GLOBAL LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE FORECAST BY FORMULATION, THROUGH 2011 ($ MILLIONS)

FIGURE 19 GLOBAL LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE FORECAST BY FORMULATION, 2004-2011 ($ MILLIONS)

TABLE 22 GLOBAL LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2006 (%)

FIGURE 20 GLOBAL LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2006 (%)

CONTRACT MANUFACTURE OF SEMISOLID DOSAGE

FORMULATIONS

Market Leaders

Market Revenue

TABLE 23 GLOBAL SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, THROUGH 2011 ($ MILLIONS)

FIGURE 21 GLOBAL SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, 2004-2011 ($ MILLIONS)

Market Shares

TABLE 24 GLOBAL SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)

FIGURE 22 GLOBAL SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)

Market by Formulation

TABLE 25 GLOBAL SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE FORECAST BY FORMULATION, THROUGH 2011 ($ MILLIONS)

FIGURE 23 GLOBAL SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE FORECAST BY FORMULATION, 2004-2011 ($ MILLIONS)

TABLE 26 GLOBAL SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2006 (%)

FIGURE 24 GLOBAL SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2006 (%)

CONTRACT MANUFACTURE OF ADVANCED DRUG

DELIVERY PRODUCTS

Contract Manufacture of…(Continued)

Partnerships

Market Leaders

TABLE 27 CONTRACTING COMPANIES PROVIDING DRUG DELIVERY SYSTEMS

Market Outlook

Market Revenue

TABLE 28 GLOBAL CONTRACTING COMPANIES PROVIDING ADVANCED DRUG DELIVERY SYSTEMS REVENUE FORECAST BY TYPE, THROUGH 2011 ($ BILLIONS)

FIGURE 25 GLOBAL ADVANCED DRUG DELIVERY SYSTEM CONTRACT MANUFACTURING REVENUE FORECAST BY TYPE, 2004-2011 ($ BILLIONS)

Market Shares

TABLE 29 GLOBAL ADVANCED DRUG DELIVERY SYSTEM CONTRACT MANUFACTURING SHARE BY TYPE, 2006 (%)

FIGURE 26 GLOBAL ADVANCED DRUG DELIVERY SYSTEM CONTRACT MANUFACTURING REVENUE BY TYPE, 2006 (%)

CONTRACT MANUFACTURE OF OTC AND NUTRITIONAL

PRODUCTS

Market Leaders

Market Revenue

TABLE 30 GLOBAL OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, THROUGH 2011 ($ BILLIONS)

FIGURE 27 GLOBAL OTC AND NUTRITIONAL PRODUCTS CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, 2004-2011 ($ BILLIONS)

Market Shares

TABLE 31 GLOBAL OTC AND NUTRITIONAL PRODUCTS CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)

FIGURE 28 GLOBAL OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)

Market by Formulation

TABLE 32 GLOBAL OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING REVENUE FORECAST BY DOSAGE FORM, THROUGH 2011 ($ BILLIONS)

FIGURE 29 GLOBAL OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING REVENUE FORECAST BY DOSAGE FORM, 2004-2011 ($ BILLIONS)

TABLE 33 GLOBAL OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING MARKET SHARES BY DOSAGE FORM, 2006 (%)

FIGURE 30 GLOBAL OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING MARKET SHARES BY DOSAGE FORM, 2006 (%)

CONTRACT RESEARCH

MARKET LEADERS

MARKET OUTLOOK

MARKET REVENUE

TABLE 34 GLOBAL CONTRACT PHARMACEUTICAL RESEARCH MARKET FORECAST BY REGION, THROUGH 2011 ($ BILLIONS)

FIGURE 31 GLOBAL CONTRACT PHARMACEUTICAL RESEARCH MARKET FORECAST BY REGION, 2004-2011 ($ BILLIONS)

MARKET SHARES

TABLE 35 GLOBAL CONTRACT RESEARCH MARKET SHARES BY REGION, 2006 (%)

FIGURE 32 GLOBAL CONTRACT RESEARCH MARKET SHARES BY REGION, 2006 (%)

MARKET BY DISCIPLINE

TABLE 36 GLOBAL CONTRACT RESEARCH REVENUE FORECAST BY DISCIPLINE, THROUGH 2011 ($ BILLIONS)

FIGURE 33 GLOBAL CONTRACT RESEARCH REVENUE FORECAST BY DISCIPLINE, 2004-2011 ($ BILLIONS)

MARKET SHARES BY DISCIPLINE

TABLE 37 GLOBAL CONTRACT RESEARCH MARKET SHARES BY DISCIPLINE, 2006 (%)

FIGURE 34 GLOBAL CONTRACT RESEARCH MARKET SHARES BY DISCIPLINE, 2006 (%)

CONTRACT PACKAGING

MARKET LEADERS

MARKET REVENUE

TABLE 38 GLOBAL CONTRACT PACKAGING MARKET FORECAST BY REGION, THROUGH 2011 ($ BILLIONS)

FIGURE 35 GLOBAL CONTRACT PACKAGING MARKET FORECAST BY REGION, 2004-2011 ($ BILLIONS)

MARKET SHARES

TABLE 39 GLOBAL CONTRACT PACKAGING MARKET SHARES BY REGION, 2006 (%)

FIGURE 36 GLOBAL CONTRACT PACKAGING MARKET SHARES BY REGION, 2006 (%)

MARKET BY PACKAGE TYPE

MARKET REVENUE

TABLE 40 GLOBAL CONTRACT PACKAGING MARKET FORECAST BY PACKAGE TYPE, THROUGH 2011 ($ BILLIONS)

FIGURE 37 GLOBAL CONTRACT PACKAGING MARKET FORECAST BY PACKAGE TYPE, 2004-2011 ($ BILLIONS)

MARKET SHARES

TABLE 41 GLOBAL CONTRACT PACKAGING MARKET SHARES BY PACKAGE TYPE, 2006 (%)

FIGURE 38 GLOBAL CONTRACT PACKAGING MARKET SHARES BY PACKAGE TYPE, 2006 (%)

CONTRACT MANUFACTURING APPLICATIONS CARDIOVASCULAR DRUG MARKET MARKET REVENUE

TABLE 42 GLOBAL CONTRACT MANUFACTURE OF CARDIOVASCULAR DRUGS REVENUE FORECAST BY REGION, THROUGH 2011 ($ MILLIONS)

FIGURE 39 GLOBAL CARDIOVASCULAR DRUG CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, 2004 2011 ($ MILLIONS)

REPRODUCTIVE DRUG MARKET

MARKET REVENUE

TABLE 43 GLOBAL REPRODUCTIVE DRUG CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, THROUGH 2011 ($ MILLIONS)

FIGURE 40 GLOBAL REPRODUCTIVE DRUG CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, 2004-2011 ($ MILLIONS)

ONCOLOGY DRUG AND DIAGNOSTICS MARKET

MARKET REVENUE

TABLE 44 GLOBAL ONCOLOGY DRUG AND DIAGNOSTIC CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, THROUGH 2011 ($ MILLIONS)

FIGURE 41 GLOBAL ONCOLOGY DRUG AND DIAGNOSTIC CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, 2004-2011 ($ MILLIONS)

ANALGESIC MARKET

MARKET REVENUE

TABLE 45 GLOBAL ANALGESIC CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, THROUGH 2011 ($ MILLIONS)

FIGURE 42 GLOBAL ANALGESIC CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, 2004-2011 ($ MILLIONS)

ANTIVIRAL DRUGS MARKET

MARKET REVENUE

TABLE 46 GLOBAL ANTIVIRAL DRUG CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, THROUGH 2011 ($ MILLIONS)

FIGURE 43 GLOBAL ANTIVIRAL DRUG CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, 2004 2011 ($ MILLIONS)

ANTIBIOTICS MARKET

MARKET REVENUE

TABLE 47 GLOBAL ANTIBIOTIC CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, THROUGH 2011 ($ MILLIONS)

FIGURE 44 GLOBAL ANTIBIOTIC CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, 2004-2011 ($ MILLIONS)

MARKET FOR OTHER DRUGS

MARKET REVENUE

TABLE 48 GLOBAL OTHER DRUG CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, THROUGH 2011 ($ BILLIONS)

FIGURE 45 GLOBAL OTHER DRUG CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, 2004-2011 ($ BILLIONS)

PATENT ANALYSIS PATENTS BY YEAR

TABLE 49 NUMBER OF PATENTS BY YEAR, 2005-2007

FIGURE 46 NUMBER OF PATENTS BY YEAR, 2005-2007

FIGURE 47 NUMBER OF PATENTS BY YEAR, 2005-2007 (%)

PATENTS BY COMPANY

TABLE 50 NUMBER OF U.S. PATENTS BY COMPANY, 2005-2007

FIGURE 48 NUMBER OF U.S. PATENTS BY COMPANY, 2005-2007

PATENTS BY COUNTRY

TABLE 51 NUMBER OF U.S. PATENTS BY COUNTRY, 2005-2007

FIGURE 49 NUMBER OF U.S. PATENTS BY COUNTRY, 2005-2007

TABLE 52 PATENT SHARES BY COUNTRY, 2005-2007 (%)

FIGURE 50 PATENT SHARES BY COUNTRY, 2005-2007 (%)

PATENTS BY EMPHASIS

TABLE 53 PATENTS BY EMPHASIS, 2005-2007

FIGURE 51 NUMBER OF U.S. PATENTS BY COUNTRY, 2005-2007

SIGNIFICANT PATENTS OF 2006

TABLE 54 SIGNIFICANT PATENTS IN RESEARCH AND DEVELOPMENT, 2006

TABLE 54 (CONTINUED)

TABLE 55 SIGNIFICANT PATENTS IN DRUG DELIVERY, 2006

TABLE 55 (CONTINUED)

CURRENT ENVIRONMENT CURRENT ENVIRONMENT THE NEED HOW MUCH AND WITH WHOM OPEN OPTIONS GLOBALIZATION FROM WEST TO EAST CURRENT EUROPEAN CONTRACT MANUFACTURING ENVIRONMENT OUTSOURCING CHALLENGES FOR VIRTUAL PHARMACEUTICAL COMPANIES LEGAL CONTRACT-BID WORK VENDOR SELECTION COMMON MISTAKES MADE BY VIRTUAL COMPANIES IN VENDOR SELECTION PROJECT MANAGEMENT

COMPANY PROFILES AAIPHARMA, INC. ADVANCED POLYMER PHARMA, INC. (A.P. PHARMA) AEROGEN, INC ALBANY MOLECULAR RESEARCH, INC. ALCAN PACKAGING ALKERMES ALMAC ALPHARMA USPD, INC ALZA CORP. (J&J CO.) AMCOR LIMITED APPTEC LABORATORIES APTUIT ARADIGM CORP ASTER-CEPHAC ATRIX LABORATORIES (QLT) BAXTER PHARMACEUTICAL SOLUTIONS BEN VENUE LABORATORIES (SUBSIDIARY OF BOEHRINGER INGELHEIM) BIORELIANCE CORP. (AVISTA CAPITAL PARTNERS) CAMBREX CORP. CANGENE CARBOGEN AMCIS AG CARDINAL HEALTH CEDARBURG PHARMACEUTICALS, LTD CHEMBRIDGE CORP CONFAB LABORATORIES DAVOS CHEMICAL CORP DECODE GENETICS DIOSYNTH RTP DOWPHARMA DPT LABORATORIES, LTD DR. REDDY’S LABORATORIES DSM PHARMACEUTICALS EVOTEC AG FULCRUM PHARMA, PLC GENZYME PHARMACEUTICALS GILEAD GIRINDUS GLAXOSMITHKLINE BIOPHARMACEUTICALS HOVIONE S.A ICOS CORP. KV PHARMACEUTICAL CO LYNE LABORATORIES MALLINCKRODT PHARMACEUTICALS (OUTSOURCING) MDS PHARMA SERVICES MEDAREX, INC. MIKART MOVA PHARMACEUTICAL CORP NICHOLAS PIRAMAL INDIA, LTD. NOVAVAX, INC ORTEC, INC OSG NORWICH PHARMACEUTICALS PATHEON PHARMACOPEIA DRUG DISCOVERY, INC PRECISION PHARMA SERVICES QUINTILES, INC. RANBAXY RESEARCH LABS REGIS TECHNOLOGIES, INC. SCHWARZ PHARMA SKYEPHARMA TETRIONICS, INC. XCELLEREX, LLC

APPENDIX I. ABBREVIATIONS

LIST OF TABLES

SUMMARY TABLE GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING AND CONTRACT RESEARCH ORGANIZATIONS REVENUE FORECAST, THROUGH 2011 ($ BILLIONS)